ICOSF
Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers foundation and concealers, highlighters, bronzers, blushes, primers, face powders, eyeshadows, delivery systems and pencils, mascara, lipsticks and glosses, nail lacquers, face and eye care p… Read more
ICOSF (ICOSF) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, ICOSF (ICOSF) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | 37.0% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 39.63 |
ICOSF - Net Assets Trend (2020–2024)
This chart illustrates how ICOSF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ICOSF (2020–2024)
The table below shows the annual net assets of ICOSF from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $478.86 Million | +6.52% |
| 2023-12-31 | $449.54 Million | +7.55% |
| 2022-12-31 | $418.00 Million | +103.24% |
| 2021-12-31 | $205.67 Million | +51.31% |
| 2020-12-31 | $135.92 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ICOSF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 470.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $356.92 Million | 74.87% |
| Other Components | $119.80 Million | 25.13% |
| Total Equity | $476.72 Million | 100.00% |
ICOSF Competitors by Market Cap
The table below lists competitors of ICOSF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sichuan Huiyu Pharmaceutical Co Ltd
SHG:688553
|
$514.70 Million |
|
TOWA PHARMA. CO.
F:6QC
|
$514.92 Million |
|
Hwang Chang General Contractor Co Ltd
TW:2543
|
$514.98 Million |
|
Ningbo Donly Co Ltd
SHE:002164
|
$515.03 Million |
|
Luolai Home Textile Co Ltd
SHE:002293
|
$514.67 Million |
|
Changzhou Tenglong Auto Parts
SHG:603158
|
$514.23 Million |
|
Nan Pao Resins Chemical Co Ltd
TW:4766
|
$514.20 Million |
|
Close Brothers Group plc
PINK:CBGPF
|
$514.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ICOSF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 447,504,000 to 476,722,000, a change of 29,218,000 (6.5%).
- Net income of 48,524,000 contributed positively to equity growth.
- Dividend payments of 18,000,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $48.52 Million | +10.18% |
| Dividends Paid | $18.00 Million | -3.78% |
| Other Changes | $-1.31 Million | -0.27% |
| Total Change | $- | 6.53% |
Book Value vs Market Value Analysis
This analysis compares ICOSF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.66x to 3.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $1.42 | $17.97 | x |
| 2021-12-31 | $2.15 | $17.97 | x |
| 2022-12-31 | $4.32 | $17.97 | x |
| 2023-12-31 | $4.65 | $17.97 | x |
| 2024-12-31 | $4.95 | $17.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ICOSF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.18%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.56%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 2.20x
- Recent ROE (10.18%) is above the historical average (6.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -14.41% | -49.09% | 0.08x | 3.52x | $-33.18 Million |
| 2021 | 13.11% | 4.00% | 1.42x | 2.30x | $6.40 Million |
| 2022 | 10.77% | 5.36% | 0.85x | 2.37x | $3.21 Million |
| 2023 | 11.70% | 5.30% | 1.01x | 2.19x | $7.59 Million |
| 2024 | 10.18% | 4.56% | 1.01x | 2.20x | $851.80K |
Industry Comparison
This section compares ICOSF's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ICOSF (ICOSF) | $- | -14.41% | N/A | $514.68 Million |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |